this fact , coupled with in vitro investigations showing growth inhibitory or cytotoxic effects of interferon ( ifn ) on renal cell carcinoma and melanoma cell lines , led to phase ii clinical trials with recombinant ( r ) ifn-alpha 2c and rifn-gamma .
C0021747
interferon
C0007134
renal cell carcinoma